Immuneering Corporation (IMRX) is expected to be added to the Nasdaq Biotechnology Index (NBI). Immuneering’s addition will become effective prior to market open on Monday, December 22, 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMRX: